Jeffrey S. Shenberger, MD
- Professor, Pediatrics - Neonatology

Jeffrey S. Shenberger, MD
- Professor, Pediatrics - Neonatology
Research Interests
- Infant, Newborn, Diseases
- Clinical Trials
- Neonatal Opiate Withdrawal Syndrome
- Education
- BA, Franklin and Marshall College, 1984
- MD, Pennsylvania State University - Hershey Medical Center, 1989
- Board Certifications
- American Board of Pediatrics, Neonatal-Perinatal Medicine
- Positions
- Section Head, Pediatrics - Neonatology
- Professor, Pediatrics - Neonatology
- Departments and Affiliations
- Pediatrics - Neonatology
- Center for Redox Biology and Medicine
Research
- CpG methylation patterns in placenta and neonatal blood are differentially associated with neonatal inflammation. Eaves LA, Enggasser AE, Camerota M, Gogcu S, Gower WA, Hartwell H, Jackson WM, Jensen E, Joseph RM, Marsit CJ, Roell K, Santos HP, Shenberger JS, Smeester L, Yanni D, Kuban KCK, O'Shea TM, Fry RC. Pediatr Res. 2022 Jun;
- Partnering with parents to improve outcomes for substance exposed newborns-a pilot program. Singh R, Rothstein R, Ricci K, Visintainer P, Shenberger J, Attwood E, Friedmann P. J Perinatol. 2020 07; 40(7):1041-1049.
- Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome. Czynski AJ, Davis JM, Dansereau LM, Engelhardt B, Marro P, Bogen DL, Hudak ML, Shenberger J, Wachman EM, Oliveira EL, Lester BM. J Pediatr. 2020 04; 219:146-151.e1.
- The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity. Davis JM, Pilon AL, Shenberger J, Breeze JL, Terrin N, Mazela J, Gulczynska E, Lauterbach R, Parad R. Pediatr. Res. 2019 08; 86(2):254-260.
- Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial. Davis JM, Shenberger J, Terrin N, Breeze JL, Hudak M, Wachman EM, Marro P, Oliveira EL, Harvey-Wilkes K, Czynski A, Engelhardt B, D'Apolito K, Bogen D, Lester B. JAMA Pediatr. 2018 08; 172(8):741-748.